Growth Metrics

Ptc Therapeutics (PTCT) Amortization - Intangibles (2017 - 2025)

Historic Amortization - Intangibles for Ptc Therapeutics (PTCT) over the last 9 years, with Q3 2025 value amounting to $7.5 million.

  • Ptc Therapeutics' Amortization - Intangibles rose 14815.55% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.7 million, marking a year-over-year decrease of 8610.75%. This contributed to the annual value of $60.7 million for FY2024, which is 7271.86% down from last year.
  • Ptc Therapeutics' Amortization - Intangibles amounted to $7.5 million in Q3 2025, which was up 14815.55% from $4.1 million recorded in Q2 2025.
  • In the past 5 years, Ptc Therapeutics' Amortization - Intangibles registered a high of $77.2 million during Q4 2023, and its lowest value of $2.9 million during Q2 2024.
  • Over the past 5 years, Ptc Therapeutics' median Amortization - Intangibles value was $16.4 million (recorded in 2021), while the average stood at $24.8 million.
  • Per our database at Business Quant, Ptc Therapeutics' Amortization - Intangibles plummeted by 9571.49% in 2024 and then surged by 14815.55% in 2025.
  • Over the past 5 years, Ptc Therapeutics' Amortization - Intangibles (Quarter) stood at $16.4 million in 2021, then surged by 118.5% to $35.8 million in 2022, then soared by 115.51% to $77.2 million in 2023, then plummeted by 95.71% to $3.3 million in 2024, then soared by 127.82% to $7.5 million in 2025.
  • Its last three reported values are $7.5 million in Q3 2025, $4.1 million for Q2 2025, and $3.8 million during Q1 2025.